Invokana is not currently available as a generic medication.
When might generic Invokana become available?
The patent for Invokana (canagliflozin) is set to expire in 2028, according to DrugPatentWatch.com [1]. This expiration date typically signals when generic versions could potentially enter the market, assuming no other intellectual property protections or legal challenges extend its exclusivity.
What is Invokana used for?
Invokana is a prescription medication used to improve blood sugar control in adults with type 2 diabetes [2]. It is also prescribed to reduce the risk of major cardiovascular events such as heart attack, stroke, or cardiovascular death in adults with type 2 diabetes and established cardiovascular disease [2]. Additionally, it is indicated to reduce the risk of end-stage kidney disease, kidney failure, kidney-related hospitalization, and cardiovascular death in certain patients with type 2 diabetes and diabetic kidney disease [2].
How does Invokana work?
Invokana belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors [2]. It works by blocking the reabsorption of glucose in the kidneys, which leads to more glucose being removed from the body through urine [2].
What are the potential side effects of Invokana?
Common side effects of Invokana can include urinary tract infections, yeast infections, changes in urination patterns, and nausea [2]. More serious, though less common, side effects can occur, such as ketoacidosis, severe dehydration, and a rare but serious infection of the genital area called Fournier's gangrene [2].
Are there other SGLT2 inhibitors available?
Yes, other SGLT2 inhibitors are on the market, including Jardiance (empagliflozin), Farxiga (dapagliflozin), and Steglatro (ertugliflozin) [3]. These medications share a similar mechanism of action but may have differences in their approved indications, side effect profiles, and clinical trial data [3].
What is the difference between brand-name and generic drugs?
Brand-name drugs are developed and marketed by the pharmaceutical company that originally innovated the medication. Generic drugs are typically bioequivalent to their brand-name counterparts, meaning they contain the same active ingredient, dosage form, strength, and route of administration. They are generally approved for marketing after the patents and market exclusivity of the brand-name drug expire [4].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.invokana.com/
[3] https://www.fda.gov/
[4] https://www.fda.gov/drugs/generic-drugs/what-generic-drug